Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
May 16, 2013 UA spin-off launches clinical trial -
May 06, 2013 UA, Glendale honored in Clinical Trial of the Year
-
Apr 15, 2013 First class of AACR Fellows named
-
Apr 15, 2013 Drugs effective against tumors, studies show
Share on Twitter
Share on Facebook
Email to a friend
Print Article
TGen and Scottsdale Healthcare discover new ‘pathways’
[Source: TGen] - Using computer modeling, the Translational Genomics Research Institute and Scottsdale Healthcare have discovered lung cancer ‘pathways’ that could become targets for new drugs, according to a scientific paper published online today by the Journal of Thoracic Oncology.
Dr. Glen Weiss, Director of Thoracic Oncology at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare, said the study showed the value of conducting computer modeling, or “in silico” research.
TCRS is a partnership of TGen and Scottsdale Healthcare. The partnership allows molecular and genomic discoveries made by TGen and others around the world to reach the patient bedside in the Virginia G. Piper Cancer Center at Scottsdale Healthcare as quickly as possible through clinical trials with agents directed at specific cancer targets.
Researchers hope that over time in silico research will help lower health care costs while speeding up the process of turning scientific discoveries into treatments for patients.
For more information: TGen and Scottsdale Healthcare discover new ‘pathways’
Quick Links
- Arizona Biosciences Video
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Newsletter Signup
- Arizona Center for Civic Leadership
“A Bridge Crossed,” a brochure featuring the 2012 progress of Arizona’s Bioscience Roadmap, as well as "Performance Assessment 2002-12," featuring the latest bioscience sector data from Battelle Technology Partnership Practice, are now available.
